ARTICLE

FindCenter AddIcon

Meet the Women Who Regularly Microdose Psychedelics

By Sophie Williams — 2021

From Gwyneth Paltrow’s Goop promoting the healing benefits of 'magic mushroom therapy' to success-hungry professionals, there's an ongoing mental health revolution being fuelled by 'natural medicines' that can’t be found over the counter.

Read on www.cosmopolitan.com

FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon
FindCenter Post-Image

The Psychosocial Side of Cancer

A cancer diagnosis brings a wealth of psychological challenges. In fact, adults living with cancer have a six-time higher risk for psychological disability than those not living with cancer.

Article
Suzanne M. Miller
2020
FindCenter AddIcon
FindCenter Post-Image

One Dose of ‘Magic Mushroom’ Drug Reduces Anxiety and Depression in Cancer Patients, Study Says

A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds.

Article
Meera Senthilingam
2020
FindCenter AddIcon
FindCenter Post-Image

Single Dose of Psychedelic Drug Eased Cancer Patients’ Anxiety, Depression for Years

The new research looked at cancer patients who took part in a study nearly five years ago.

Article
Kaitlin Sullivan
2020
FindCenter AddIcon
FindCenter Post-Image

Experimental Treatments Changed the Course of the AIDS Epidemic; We Need the Same Approach to Mental Illness Today | Commentary

Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.

Article
Monnica Williams, Morgan Campbell
2021
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Therapy May Work as Well as Common Antidepressant

The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.

Article
Zoe Cormier
2021
FindCenter AddIcon
FindCenter Post-Image

Are Psychedelics the Answer to Depression and Addiction?

A new generation of research into psilocybin could change how we treat numerous mental health conditions.

Article
Johann Hari
2018
FindCenter AddIcon
FindCenter Post-Image

Coping with Depression and Disability

Often, disabled people have their disability treated, but they don’t have their emotional or spiritual needs addressed.

Article
Charlotte Gerber
2021
FindCenter AddIcon
FindCenter Post-Image

When a Physical Disability Keeps You from Getting Mental Health Help

Depression and suicidal ideation are more likely among people with disabilities due to factors like abuse, isolation, and stressors related to poverty, among others.

Article
Heather Morrison
2020
FindCenter AddIcon
FindCenter Post-Image

What Happens When You’re Disabled But Nobody Can Tell

The author and clinical psychologist Andrew Solomon examines the disabilities that ramps and designated parking spots don’t address.

Article
Andrew Solomon
2020
FindCenter AddIcon

EXPLORE TOPIC

Microdosing